TReatment for ImmUne Mediated PathopHysiology

Summary

TReatment for ImmUne Mediated PathopHysiology is a clinical trial^[1].

Key Facts

• TReatment for ImmUne Mediated PathopHysiology is in the country of United States^[2].
• TReatment for ImmUne Mediated PathopHysiology's instance of is recorded as clinical trial^[3].
• TReatment for ImmUne Mediated PathopHysiology's start time is recorded as +2022-02-09T00:00:00Z^[4].
• TReatment for ImmUne Mediated PathopHysiology's end time is recorded as +2025-04-30T00:00:00Z^[5].
• TReatment for ImmUne Mediated PathopHysiology's main subject is recorded as hepatic encephalopathy^[6].
• TReatment for ImmUne Mediated PathopHysiology's main subject is recorded as liver failure^[7].
• TReatment for ImmUne Mediated PathopHysiology's number of participants is recorded as {'unit': '1', 'amount': '+160'}^[8].
• TReatment for ImmUne Mediated PathopHysiology's title is recorded as A Phase 2b, Double-Blind, Three Arm, Randomized, Placebo Controlled Trial With Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatric Patients^[9].
• TReatment for ImmUne Mediated PathopHysiology's short name is recorded as TRIUMPH^[10].
• TReatment for ImmUne Mediated PathopHysiology's ClinicalTrials.gov ID is recorded as NCT04862221^[11].
• TReatment for ImmUne Mediated PathopHysiology's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[12].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as anesthetic^[13].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as (±)-promethazine^[14].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as methylprednisolone^[15].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as methylprednisolone acetate^[16].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as methylprednisolone hemisuccinate^[17].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as prednisolone^[18].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as prednisolone acetate^[19].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as prednisolone hemisuccinate^[20].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as prednisolone 21-phosphate^[21].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as anti-lymphocyte globulin^[22].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as non-steroidal anti-inflammatory drug^[23].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as antiemetic^[24].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as peripheral nervous system agent^[25].
• TReatment for ImmUne Mediated PathopHysiology's research intervention is recorded as gastrointestinal agent^[26].